Cognizant Technology Solutions (CTSH)
(Delayed Data from NSDQ)
$81.36 USD
+1.96 (2.47%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $81.36 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$81.36 USD
+1.96 (2.47%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $81.36 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth D Momentum B VGM
Zacks News
Cognizant (CTSH) Partners With Accuray to Improve Healthcare
by Zacks Equity Research
Cognizant's (CTSH) partnership agreement will enable Accuray to streamline and drive operational changes to improve patient care.
Cognizant (CTSH) Partners With Orkla to Redefine IT Services
by Zacks Equity Research
Cognizant's (CTSH) partnership-extension agreement will enable Orkla to modernize and improve its IT services.
Cognizant (CTSH) Creates New Group to Expand Into Blue Economy
by Zacks Equity Research
Cognizant (CTSH) forms Cognizant Ocean to expand its services among Blue Economy companies.
Cognizant (CTSH) Accelerates Generative AI Adoption at Scale
by Zacks Equity Research
Cognizant (CTSH) launches Cognizant Neuro AI platform, enabling enterprises to adopt and harness generative AI at scale, reflecting a strong product portfolio and partner base.
5 Stocks That Powered Nasdaq ETF Last Week
by Sweta Killa
The tech-heavy Nasdaq Composite Index managed to end the week in green and move toward yearly highs amid volatile trading.
Cognizant (CTSH) Q1 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Cognizant's (CTSH) first-quarter 2023 results benefit from strong Health Sciences revenues and acquisitions amid a challenging macro environment.
Cognizant (CTSH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Cognizant (CTSH) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cognizant (CTSH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cognizant (CTSH) delivered earnings and revenue surprises of 5.71% and 1.60%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Cognizant's (CTSH) first-quarter 2023 results are expected to reflect growing domain expertise in its digital and healthcare business operations despite challenging macroeconomic conditions.
Analysts Estimate Cognizant (CTSH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cognizant (CTSH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cognizant (CTSH) & Microsoft Expand Healthcare Partnership
by Zacks Equity Research
Cognizant (CTSH) announces the expansion of its partnership with Microsoft in the healthcare market by integrating its TriZetto with Microsoft Cloud for Healthcare.
Is First Trust Rising Dividend Achievers ETF (RDVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RDVY
Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FVD
NICE (NICE) Hits a Count of One Million Agents on CXone
by Zacks Equity Research
NICE (NICE) records a milestone of crossing one million agents using CXone, suggesting expanding clientele and a strong partner base.
Should You Invest in the First Trust NASDAQ-100-Technology Sector ETF (QTEC)?
by Zacks Equity Research
Sector ETF report for QTEC
Is First Trust NASDAQ-100-Technology Sector ETF (QTEC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QTEC
Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FVD
Should First Trust Rising Dividend Achievers ETF (RDVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RDVY
Cognizant (CTSH) Q4 Earnings Meet Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Cognizant's (CTSH) fourth-quarter 2022 results benefit from strong digital revenues and acquisitions amid a challenging macro environment.
Cognizant (CTSH) Matches Q4 Earnings Estimates
by Zacks Equity Research
Cognizant (CTSH) delivered earnings and revenue surprises of 0% and 1.18%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Cognizant's (CTSH) fourth-quarter 2022 results are expected to reflect growing domain expertise in its digital business operations despite challenging macroeconomic conditions.
Earnings Preview: Cognizant (CTSH) Q4 Earnings Expected to Decline
by Zacks Equity Research
Cognizant (CTSH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FVD
Cognizant (CTSH) Appoints New CEO, Updates Q4 & 2022 View
by Zacks Equity Research
Cognizant (CTSH) Hires Ravi Kumar as the CEO, replacing Brian Humphries, effective immediately. It also updates its fourth-quarter and 2022 guidance.
Cognizant (CTSH) Set to Acquire Consultancy Firm Utegration
by Zacks Equity Research
Cognizant (CTSH) to acquire Utegration LLC to boost digital transformation in the energy and utilities sectors.